The EMA’s Committee for Medicinal Products for Human Use said the agency should improve its communications relating to GMPs and inspection in dealing with the World Health Organization and regulatory bodies in target countries.
One way to reconcile different GMPs and gaps in the quality part of the assessment would be to append the WHOs Quality Information Summaries to CHMP medicine reports, the workshop concluded.
FDAnews: FDAnews Drug Daily Bulletin Pharmaceuticals / Quality
> Do not hesitate, we look forward to your feedback!
Write a comment on this news.